SFS Group generated dynamic sales growth in business year 2017
News – 9. March 2018
2017 was a successful year. SFS Group generated dynamic sales growth and improved its position in the medical device industry and in the Americas, thanks to the integration of Tegra Medical. Operating profit showed double-digit growth.
Driven by strong organic growth of 7.4% and the first-time consolidation of Tegra Medical, SFS Group increased its sales in the 2017 financial year by 13.7% to CHF 1,632.7 million. All segments contributed to this pleasing development. Changes in the scope of consolidation had a positive impact of 5.8% and currency movements added 0.5% to reported sales.
Financial statements 2017 according to Swiss GAAP FER
For the first time, Swiss GAAP FER accounting standards were used to prepare the financial statements for 2017 instead of IFRS. These standards are more practical for SFS Group than IFRS.
After the switch to Swiss GAAP FER and the associated shortening of the balance sheet, the equity ratio as at 31.12.2017 reaches a high 71.6% (31.12.2017 under IFRS: 80.1%). In view of this strong balance sheet, the company’s financial stability and entrepreneurial freedom remain fully intact.